Moxifloxacin‐containing 4‐month ATT regimens vs standard 6‐month ATT regimen
Death from any cause · adults with drug‐sensitive pulmonary tuberculosis
Moxifloxacin‐containing 4‐month ATT regimens showed no clear difference in death from any cause compared with standard 6‐month ATT regimen (moderate certainty).
1 finding from 1 review
- Shortened treatment regimens versus the standard regimen for drug‐sensitive pulmonary tuberculosis 2019 · Cochrane Headline outcomes onlyRR 1.06 [0.65, 1.75]3 studies · 2760 participantsModerate